Polar Capital Holdings’s Akero Therapeutics AKRO Stock Holding History

Polar Capital Holdings’s Portfolio AKRO Stock Details AKRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,058,776	Closed	-$50.3M	–	267
2025 Q3	$50.3M	Buy	+1,058,776	New	+$51.3M	0.24%	99

Other funds holding AKRO

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Polar Capital Holdings's AKRO Position: Q4 2025 in Review

Polar Capital Holdings sold out of Akero Therapeutics (AKRO) in Q4 2025, closing a stake of 1,058,776 shares — an estimated $50.3M sold.

Polar Capital Holdings first reported a position in AKRO in Q3 2025 and held it in 1 quarter. The position peaked at $50.3M in Q3 2025. 2 funds tracked by Wall St. Rank hold AKRO as of Q4 2025.

Polar Capital Holdings reported no remaining Akero Therapeutics position as of Q4 2025 after selling out during the quarter.
Polar Capital Holdings sold 1,058,776 Akero Therapeutics shares in Q4 2025, an estimated $50.3M.
Polar Capital Holdings first reported a position in Akero Therapeutics in Q3 2025 and held it in 1 quarter.
Polar Capital Holdings's Akero Therapeutics position peaked at $50.3M in Q3 2025.
2 funds tracked by Wall St. Rank held Akero Therapeutics as of Q4 2025.

Based on Polar Capital Holdings's 13F filing for Q4 2025, filed 17 Feb 2026.